Nora Frey
Angel Investor @ Seventure Partners
Nora Frey is a Series C investor at Seventure Partners focused on Medical and Biopharma. Nora studied modern biology (microbiology, biochemistry) and economics in Basel and holds a masters degree in Microbiology and a PhD in Biochemistry in the field of drug-induced autoimmune diseases from the University of Basel.She was partner at Bellevue Group, Zug, Switzerland and part of the BB Biotech management team managing up to CHF 4B inpublic and private biotech investments. In 2000 she conceived and founded Adamant Biomedical Investments AG in Basel, Switzerland.Among several other awards, Nora was voted finalist in the Ernst &Young Entrepreneur of the Year Award in Switzerland. She was responsible for the establishment of a subsidiary of Adamant, Adamant Ventures Ltd., in Edinburgh, UK.Towards the end of 2008, Nora left Adamant to found Cederberg Advisors.Nora is a citizen of Germany and Switzerland.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Nora Frey invests in
Stages Nora Frey invests in
Countries Nora Frey invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Biopharma 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Series C 1 (50%)
- Series D 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System (CNS) Therapeutics to improve the quality of life for people with CNS diseases and disorders. | $37.3M / Series C / Oct 13, 2021 | ||
| Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System (CNS) Therapeutics to improve the quality of life for people with CNS diseases and disorders. | $20M / Series D |
Co-Investors
About Seventure Partners
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Seventure Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adrien Caetano
Gestionnaire Middle & Back Office
|
|||
Ana Salas
assistant
|
|||
Bruno Rivet
General Partner & Associate Director
|
|||
David Manjarres
Head of ICT Department - General Partner
|
|||
Denise Kelly
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Nora Frey invest in?
Nora Frey invests primarily in Medical, Biopharma and Biotechnology startups, most often at Series C and Series D stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Nora Frey?
Public channels for Nora Frey include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Nora Frey last invest?
The most recent investment recorded for Nora Frey closed in Oct 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
